With clinical trials under pressure, industry leaders say it’s time for reform, digital transformation, and more patient-centric models.

In the P304 Phase III study, Moderna’s mRNA-1010 demonstrated a 26.6% relative efficacy over a standard-dose flu vaccine in adults aged 50+, showing consistent protection across strains and age groups ...

UK & Ireland, experts provided insights on market trends within the clinical trial industry and advice on engagement strategies.

Real-world data (RWD), artificial intelligence (AI), and patient-centric trial design lead pharma priorities in 2025, but ...

Contingency management interventions for stimulant and opioid use disorders should offer $128 per week for vouchers or $55 ...

Baystreet.ca News Commentary – Cancer rates are climbing across the U.S., with stark disparities from state to state. Recent ...

Patients with abnormal findings had worse outcomes down the road. Still unknown is exactly how to modify that risk.

Initial human trials, launched in 2022, have shown encouraging results. Volunteers were able to tolerate the artificial blood ...

A recent study found that only 15% of cancer survivors discussed trials with their healthcare providers, with ...

Introduction Patients with cancer frequently suffer from psychological distress, including anxiety and depression, which negatively impacts their quality of life. Music therapy (MT)and Tai Chi ...

Variation in PICU mortality by ethnicity and area-level deprivation highlights the importance of further investigation into ...